Basic Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1349-1365
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1349
Figure 5
Figure 5 Expression of damage associated molecular patterns on the surface of peripheral blood and tumour-infiltrating T cells. The expression of HMGB1 and calreticulin was determined on the surface of peripheral blood and tumour-infiltrating A) CD45- and CD45+ cells and B) CD3+, CD3+CD4+, CD3+CD8+, in treatment-naïve and post-treatment OAC whole blood (WB) (n = 14 pre-treatment, n = 10 post-treatment) and tumour biopsy tissue (Bx) (n = 10 pre-treatment, n = 9 post-treatment) ex vivo by flow cytometry. Wilcoxon rank test, aP < 0.05, bP < 0.001. Treatments: FLOT n = 5 and CROSS n = 5.